Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This study is a multicentric trial evaluating the efficacy of the RFM regimen in patients
aged 18 to 75 years with relapsed/refractory follicular non-Hodgkin's lymphoma (NHL).